Table 2.
Signaling pathway | P-value |
---|---|
Integrin cell surface interactions | 7.05E-05 |
Extracellular matrix organization | 1.11E-04 |
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell | 0.002 |
TNF signaling pathway | 0.002 |
Leukocyte transendothelial migration | 0.003 |
EPH-ephrin signaling | 0.003 |
Bladder cancer | 0.004 |
Degradation of the extracellular matrix | 0.005 |
VEGF ligand–receptor interactions | 0.008 |
VEGF binds to VEGFR leading to receptor dimerization | 0.008 |
Apoptotic cleavage of cell adhesion proteins | 0.010 |
Alzheimer disease-presenilin pathway | 0.013 |
Alpha9 beta1 integrin signaling events | 0.013 |
NF-kappa B signaling pathway | 0.019 |
Rheumatoid arthritis | 0.019 |
Syndecan-4-mediated signaling events | 0.020 |
Cytokine–cytokine receptor interaction | 0.022 |
Interleukin receptor SHC signaling | 0.025 |
Adherens junctions interactions | 0.028 |
Plasminogen activating cascade | 0.028 |
Activation of matrix metalloproteinases | 0.028 |
VEGFR2-mediated cell proliferation | 0.028 |
EPHA-mediated growth cone collapse | 0.029 |
Cytokine signaling in immune system | 0.031 |
Apoptotic cleavage of cellular proteins | 0.033 |
Axon guidance mediated by Slit/Robo | 0.033 |
Nuclear signaling by ERBB4 | 0.034 |
Sumoylation as a mechanism to modulate ctbp-dependent gene responses | 0.038 |
Axon guidance | 0.038 |
Interleukin-2 signaling | 0.041 |
Pertussis toxin-insensitive ccr5 signaling in macrophage | 0.042 |
G beta:gamma signaling through PI3K gamma | 0.042 |
Interleukin-3 and -5 and GM-CSF signaling | 0.043 |
Cell adhesion molecules | 0.043 |
EPH-ephrin-mediated repulsion of cells | 0.044 |
Apoptotic execution phase | 0.045 |
GPVI-mediated activation cascade | 0.045 |
G-protein beta:gamma signaling | 0.045 |
G-protein signaling through tubby proteins | 0.046 |
Assembly of collagen fibrils and other multimeric structures | 0.048 |
Abbreviations: SPOP, speckle-type POZ protein; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor; VEGFR, VEGF receptor; GM-CSF, granulocyte–macrophage colony-stimulating factor; EPH, ephrin; NF, nuclear factor; SHC, src homology 2 domain-containing transforming protein C; EPHA, ephrin receptor A; ERBB4, erb-b2 receptor tyrosine kinase 4; PI3K, phosphatidylinositol-4, 5-bisphosphate 3-kinase; GPVI, glycoprotein VI.